News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
277,727 Results
Type
Article (14938)
Company Profile (282)
Press Release (262507)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (82078)
Career Advice (189)
Deals (13624)
Drug Delivery (36)
Drug Development (51506)
Employer Resources (33)
FDA (5900)
Job Trends (5345)
News (148741)
Policy (10527)
Tag
Academia (959)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (22426)
ALS (64)
Alzheimer's disease (872)
Antibody-drug conjugate (ADC) (100)
Approvals (5931)
Artificial intelligence (127)
Autoimmune disease (18)
Automation (7)
Bankruptcy (116)
Best Places to Work (4740)
BIOSECURE Act (6)
Biosimilars (45)
Biotechnology (233)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (157)
Cancer (1512)
Cardiovascular disease (119)
Career advice (164)
Career pathing (2)
CAR-T (120)
Cell therapy (337)
Cervical cancer (9)
Clinical research (41896)
Collaboration (552)
Compensation (266)
Complete response letters (13)
COVID-19 (1113)
CRISPR (43)
C-suite (166)
Cystic fibrosis (77)
Data (1554)
Denatured (11)
Depression (31)
Diabetes (140)
Diagnostics (1594)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (85)
Drug pricing (30)
Drug shortages (4)
Duchenne muscular dystrophy (90)
Earnings (30942)
Editorial (18)
Employer branding (5)
Employer resources (31)
Events (49890)
Executive appointments (467)
FDA (6628)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (507)
Gene editing (99)
Generative AI (10)
Gene therapy (256)
GLP-1 (377)
Government (1198)
Grass and pollen (2)
Guidances (27)
Healthcare (6808)
Huntington's disease (22)
IgA nephropathy (26)
Immunology and inflammation (95)
Indications (21)
Infectious disease (1186)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (21)
Intellectual property (67)
Interviews (19)
IPO (7415)
IRA (13)
Job creations (898)
Job search strategy (155)
Kidney cancer (7)
Labor market (6)
Layoffs (213)
Leadership (3)
Legal (1466)
Liver cancer (36)
Lung cancer (209)
Lymphoma (102)
Machine learning (3)
Management (7)
Manufacturing (144)
MASH (55)
Medical device (2716)
Medtech (2717)
Mergers & acquisitions (6532)
Metabolic disorders (397)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1284)
NextGen: Class of 2025 (2124)
Non-profit (908)
Now hiring (21)
Obesity (197)
Opinion (105)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (9)
Patents (132)
Patient recruitment (79)
Peanut (35)
People (26163)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14787)
Phase II (19517)
Phase III (12312)
Pipeline (832)
Policy (49)
Postmarket research (868)
Preclinical (6237)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (295)
Real estate (1536)
Recruiting (13)
Regulatory (8973)
Reports (16)
Research institute (971)
Resumes & cover letters (23)
Rett syndrome (4)
RNA editing (5)
RSV (11)
Schizophrenia (61)
Series A (100)
Series B (63)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (118)
Sponsored (12)
Startups (2006)
State (1)
Stomach cancer (4)
Supply chain (24)
Tariffs (9)
The Weekly (36)
Vaccines (249)
Venture capitalists (32)
Weight loss (115)
Women's health (15)
Worklife (2)
Date
Today (82)
Last 7 days (548)
Last 30 days (1521)
Last 365 days (19841)
2025 (6447)
2024 (20891)
2023 (22808)
2022 (27534)
2021 (28623)
2020 (24094)
2019 (16964)
2018 (12301)
2017 (14195)
2016 (12247)
2015 (14820)
2014 (10712)
2013 (7724)
2012 (7733)
2011 (7845)
2010 (7613)
Location
Africa (171)
Alabama (42)
Alaska (2)
Arizona (54)
Arkansas (5)
Asia (17746)
Australia (3045)
California (3926)
Canada (1152)
China (367)
Colorado (150)
Connecticut (152)
Delaware (105)
Europe (39380)
Florida (497)
Georgia (122)
Idaho (17)
Illinois (239)
India (12)
Indiana (93)
Iowa (2)
Japan (77)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (495)
Massachusetts (3110)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (984)
New Mexico (12)
New York (1063)
North Carolina (568)
North Dakota (5)
Northern California (1727)
Ohio (113)
Oklahoma (9)
Oregon (21)
Pennsylvania (747)
Puerto Rico (6)
Rhode Island (19)
South America (230)
South Carolina (4)
Southern California (1513)
Tennessee (25)
Texas (454)
United States (13512)
Utah (63)
Virginia (82)
Washington D.C. (30)
Washington State (353)
Wisconsin (15)
277,727 Results for "prime therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025
April 1, 2025
·
4 min read
Press Releases
GRIN Therapeutics Receives Priority Medicines (PRIME) Designation from EMA for Radiprodil in the Treatment of GRIN-Related Neurodevelopmental Disorder
April 1, 2025
·
6 min read
Press Releases
AHF Wins $10+ Million Against Prime Therapeutics in PBM Price-Fixing Arbitration
January 23, 2025
·
3 min read
Business
Prime Therapeutics hires industry veteran Mike Edwards to lead new market-focused organization
Prime Therapeutics, LLC/Magellan Rx Management announces the appointment of health care leader Mike Edwards as president, markets.
June 10, 2024
·
2 min read
Press Releases
Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
March 18, 2025
·
8 min read
Press Releases
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
March 17, 2025
·
7 min read
Business
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
Prime Therapeutics LLC/Magellan Rx Management, LLC (Prime), a leading pharmacy solutions organization, and Capital Rx, Inc. (Capital Rx), a renowned health care technology solutions provider, are announcing a strategic alliance.
March 13, 2024
·
4 min read
Press Releases
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
March 3, 2025
·
11 min read
Gene Editing
Gene Editor Prime Medicine Signs BMS Cell Therapy Deal, Reprioritizes Pipeline
In an effort to expand its cash runway beyond 12 months, Prime Medicine has signed a deal with Bristol Myers Squibb worth a potential $3.5 billion, while also streamlining its pipeline to trim costs.
September 30, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
February 25, 2025
·
2 min read
1 of 27,773
Next
